Pubertal development in cystic fibrosis: an overview

Teresa Arrigo1, I Rulli, C Sferlazzas

  • 1Department of Medical and Surgical Pediatrics, University of Messina, Italy. tarrigo@unime.it

Insights

Cystic fibrosis (CF) patients experience delayed puberty and growth, impacting reproductive health and hormone levels. This maturational lag affects insulin-like growth factor-I and gonadotropins, despite improved treatments.

Area of Science:

  • Pediatric Endocrinology
  • Genetics and Inherited Diseases
  • Pulmonology

Background:

  • Cystic fibrosis (CF) is an autosomal recessive disorder causing respiratory and intestinal issues.
  • Patients with CF often exhibit delayed growth, puberty, and menarche.
  • Infertility and menstrual dysfunction are prevalent in CF patients.

Purpose of the Study:

  • To investigate the maturational lag in cystic fibrosis patients.
  • To examine the correlation between growth failure and pulmonary disease severity.
  • To assess pubertal hormone levels in CF patients.

Main Methods:

  • Review of existing literature on CF growth and development.
  • Analysis of correlations between malnutrition, pulmonary disease, and growth.
  • Assessment of pubertal hormone levels including IGF-I, LH, FSH, and sex steroids.

Main Results:

  • CF patients show delayed puberty and growth spurts, even with enhanced nutrition and treatment.
  • A significant delay in achieving pubertal levels of IGF-I, LH, FSH, and sex steroids was observed.
  • Growth failure in CF is linked to malnutrition and the severity of lung disease.

Conclusions:

  • Cystic fibrosis leads to a distinct maturational lag affecting pubertal development.
  • Hormonal imbalances, including delayed gonadotropin and sex steroid levels, characterize this lag.
  • Intensive treatment and nutrition do not fully overcome the pubertal delay in CF.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation